All Activity

The governor of Illinois has signed a large-scale cannabis omnibus bill into law that doubles the amount of marijuana that adults can legally possess, significantly restricts hemp THC products and makes other changes to rules for how licensed businesses can operate. Gov. JB Pritzker on Friday gave final approval to the legislation, which cleared the House of Representatives and Senate about two weeks ago. As enacted into law, SB 3222 allows residents of the state who are over 21 years of age to possess up to 60 grams of marijuana flower—double the amount in prior law. They are also able to have up to 10 grams of cannabis concentrates and infused products with up to 1,000 mg of THC—also double the earlier limit. Possession amounts for adult non-residents are also doubled under the bill. People with past convictions for possession of up to 60 grams of marijuana will now be able to have those records expunged—double the previous cutoff allowing only those with convictions for up to 30 grams to be eligible. The legislation also recriminalizes hemp THC products with more than 04. milligrams of THC per container, in line with a federal ban that is set to take effect in November. “Instead of letting an ambiguous marketplace keep putting people at risk, Illinois is taking action to protect consumers of all ages, especially children, from misleading packaging and labeling,” Pritzker said in a press release. “This landmark legislation closes the intoxicating hemp loophole while bolstering equity and oversight and expanding medical access. Illinois is committed to cultivating a cannabis industry that benefits diverse businesses across the state and prioritizes accessibility, and I am proud to sign this measure into law.” Illinois continues to set the standard for opportunity, equity, and safety in the adult legal cannabis industry. Today, I’m signing legislation to ban the sale of intoxicating hemp to those under 21 to protect our kids, streamlining licensing, and strengthening oversight. pic.twitter.com/HEnEdSWe7e — Governor JB Pritzker (@GovPritzker) June 12, 2026 Among other changes, the bill also allows drive-thrus and curbside pickup at dispensaries, permits them to stay open until 2 a.m. and makes it so medical cannabis certifications can be issued via telehealth. Canopy limits for craft cannabis cultivators will be expanded form 5,000 to 14,000 square feet, and the new law loosens some security requirements for marijuana businesses while also waiving or reducing fees for smaller operators. In 2019, Pritzker signed the state’s initial marijuana legalization policy into law. While the broader restrictions on hemp products take effect in the state on November 12 in conjunction with the similar federal move, sales to people under 21 are prohibited immediately, The legislation separately allows all marijuana dispensaries to register to sell medical cannabis specifically. The list of medical marijuana qualifying conditions is also being expanded to add female orgasmic disorder, endometriosis, ovarian cysts and uterine fibroids. “Illinois has led the nation in building a cannabis industry that prioritizes both equity and public safety, and SB 3222 builds on that progress,” Lt. Gov. Juliana Stratton said. “By protecting young people from unregulated intoxicating hemp products and creating clear standards for the industry, we are ensuring consumers are safer while preserving opportunities for diverse businesses and communities across our state.” Photo courtesy of Mike Latimer. The post Illinois Governor Signs Bill To Double Marijuana Possession Limit, Restrict Hemp THC Products And Reform Rules For Businesses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“The proposed measure does not place voters in ‘the untenable position of casting a single vote on two or more dissimilar subjects.'” By Chris Lisinski, CommonWealth Beacon A controversial push to revoke recreational marijuana legalization remains on track to be decided by voters after the state’s highest court on Friday rejected a legal challenge seeking to toss the measure. The Supreme Judicial Court ruled that the attorney general’s office properly certified and summarized the question, whose campaign is funded by a national dark-money group fighting legal drug use in multiple states. If organizers collect enough signatures this month—which is nearly guaranteed given that the final haul required is far less than an earlier signature threshold—the measure will lock in a spot on the November ballot, tasking Bay Staters with choosing whether to walk back their 2016 vote to legalize and launch a multibillion-dollar recreational cannabis industry. The campaign has been fraught with controversy, both over the policy particulars and over the route taken. Earlier this year, opponents alleged that the campaign obtained signatures “fraudulently” by misleading voters and describing the question as related to affordable housing or funding public parks. The State Ballot Law Commission dismissed the challenge. The lawsuit before the SJC took another approach. In that case, plaintiffs argued that Attorney General Andrea Campbell’s (D) office should have deemed the question ineligible because it combined unrelated topics and would allow a “taking of private property without providing compensation.” They also contended that the AG’s summary failed to communicate to voters that the ballot question would eliminate marijuana industry social equity grants—which the plaintiffs themselves received—and some cannabis-related penalties. Justices disagreed. The question’s “limited effects on the regulation of medical marijuana” do not rise to an improper comingling of discrete topics, Justice Elizabeth Dewar wrote in the decision. The sections of the ballot measure that would eliminate social equity programs and mandatory host community agreements “all bear an operational relationship” to the proposal’s primary goal, she added. “As the plaintiffs argue, there indeed may be voters who favor restricting recreational marijuana but do not favor eliminating these other aspects of the current regulatory regime in relation to medical marijuana,” Dewar wrote. “Nonetheless, the proposed measure does not place voters in ‘the untenable position of casting a single vote on two or more dissimilar subjects.’” The court also ruled that the AG’s written summary is sufficient, even with a broad generalization of the existing laws the question would repeal. Justices noted, as case law has found, that “the summary is not the only source of information for voters”—a line that could play a role in a forthcoming decision about a ballot question seeking to cut the income tax rate, which also faces an eligibility challenge hinging on the official summary. Three other SJC decisions on ballot questions are expected in the coming weeks: the income tax cut, a measure seeking to revive rent control with a strict statewide cap, and a proposal to place all primary election candidates on a single ballot regardless of party. Those rulings, plus ongoing talks about compromise legislation that could replace ballot questions, will decide the final size of the field this November. If every proposal advances to the ballot, it would be a record 11 questions. This article first appeared on CommonWealth Beacon and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License. Photo elements courtesy of rawpixel and Philip Steffan. The post Massachusetts Supreme Court Rejects Challenge To Marijuana Legalization Rollback Ballot Initiative appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Nice post! This is a very nice blog that I will definitively come back to more times this year! Thanks for informative post. bandar togel

I like your post. It is good to see you verbalize from the heart and clarity on this important subject can be easily observed... gurutoto

Virginia’s governor and a key lawmaker say they have reached an agreement on a proposal to legalize recreational marijuana sales through budget legislation this month following the veto of a previous proposal to enact the reform. “Throughout this year’s legislative process, my end goal has been to finally set up a safe, well-regulated retail cannabis market in Virginia,” Gov. Abigail Spanberger (D) said on Friday, adding that she is “grateful” to lawmakers who have led on the issue “for their partnership in delivering a new framework to move forward in a way that is paced appropriately for regulators, public health officials and law enforcement.” “I look forward to sharing more specific details soon,” she said. Del. Paul Krizek (D), who sponsored the earlier measure to allow adult-use cannabis commerce and is serving as a negotiator for the budget, said on Friday that “we have a deal” on the marijuana issue. He was speaking a a press conference where House leaders unveiled their broader budget proposal, which includes cannabis reform language. Krizek said that lawmakers and Spanberger would hold a separate press conference on Tuesday focused on unveiling full details of the negotiated marijuana compromise. For now, the cannabis provisions in the House budget legislation are marked as a “placeholder” and do not necessarily reflect the final deal—though there are some notable changes from the previously passed and vetoed measure that appear to reflect certain areas of agreement between the governor, Krizek and Sen. Lashrecse Aird (D), who sponsored the Senate version of the earlier bill. For example, the new legislation sets the launch date for recreational marijuana sales at July 1, 2027, which is what Spanberger proposed in contrast to the January 1 date in what lawmakers had passed. It also sets the legal public marijuana possession and per-transaction purchase limit at 2 ounces, an increase from the current legal limit of one ounce. The legislation lawmakers passed earlier this year would have allowed adults to possess up to 2.5 ounces. The bill also cedes to Spanberger on language to increase a marijuana excise tax from 6 percent to 8 percent after two years of legal sales. By way of compromise, the new legislative text would make public consumption of marijuana punishable by a civil penalty of $250—a significant increase from the $25 in current law but less harsh than the class 4 criminal misdemeanor the governor sought in her proposed changes to the previous bill. The House budget legislation also provides a significant increase in funding for the Virginia Cannabis Control Authority to address “costs associated with the creation of a retail cannabis market.” Delegate Paul Krizek says “we have a deal” on a legal recreational marijuana market in the budget. He says there will be a press conference with Governor Spanberger next week unveiling the agreement. pic.twitter.com/kY1VofId5p — Tyler Englander (@TylerEnglander) June 12, 2026 Lawmakers passed the cannabis sales bills in March, but the governor then suggested changes to the legalization proposal—including delaying the start date for sales by six months, increasing taxes and instituting new criminal penalties for cannabis consumers. The legislature in April declined to take up the amendments during a one-day reconvened session, however, effectively rejecting them. Spanberger then issued a veto. Spanberger said earlier this week that she has been having “really productive” and “incredible” conversations with lawmakers about crafting a compromise approach to legalizing adult-use cannabis sales, and Marijuana Moment previoulsy reported on the ongoing talks. A spokesperson for Spanberger previously told Marijuana Moment that the governor “has made clear that she continues to support setting up a legal retail marketplace for cannabis that prioritizes the health and safety of Virginians, protects communities and consumers and operates with clear enforcement and regulatory authority.” The governor and the sponsors of the legalization legislation “share these same goals, and she looks forward to moving this across the finish line together,” the spokesperson said. Following Spanberger’s veto, top lawmakers have been openly discussing the possibility of including provisions to legalize adult-use cannabis sales in still-outstanding budget legislation that they are due to pass by July 1. The effort to keep the issue alive was a topic of discussion last week at the first meeting of the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market since the governor’s move to kill the previous proposal to regulate adult-use marijuana sales. The governor, meanwhile, is continuing to try to publicly explain her veto—including by saying it is her view that “taking a little bit longer” to launch the market is not something she sees as “negative” because it is more important to get the details right than to do it fast. A recent survey found that bipartisan majorities of Virginia voters wanted Spanberger to sign the cannabis legislation into law, and that they specifically disagreed with her desire to slow the launch timeline for legal sales. The governor recently acknowledged in a separate interview that “a lot of people are not pleased” with her veto of the cannabis legislation. “Friends and family are displeased as well,” she said. Spanberger has repeatedly responded to criticism of her cannabis amendments from the bill sponsors and advocates by saying the suggested changes came after she spoke to the leaders of other states that have already implemented adult-use marijuana markets. A spokesperson for Spanberger declined to name any other governors she talked to about cannabis in response to a question from Marijuana Moment, however. The governor separately recently sought to explain her veto in an earlier interview, reiterating that she supports launching a legal cannabis market but worried about what she called a “rushed timeline” and “far more stores across Virginia” than she thinks are appropriate. Prior to vetoing the cannabis commerce bill, the governor did sign separate legislation to provide resentencing relief for people with past cannabis convictions. Personal marijuana possession and home cultivation of marijuana has been legal in Virginia since 2021, but then-Gov. Glenn Youngkin (R) twice vetoed bills to provide consumers with a way to legally purchase regulated adult-use cannabis. Aird and Krizek, the sponsors of the legalization bills, had urged colleagues to vote against the governor’s amendments—even if that meant risking a veto from Spanberger when the legislation returned to her desk, which has now occurred. Here are the other key details of the cannabis bills—SB 542 and HB 642—as approved by lawmakers and with the governor’s suggested amendments prior to the newly negotiated compromise: Lawmakers voted to allow adults to be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. That would represent an increase from the limit in current law of 1 ounce. The governor, however, wanted the amount increased to only 2 ounces. Under the legislature’s plan, legal sales could begin on January 1, 2027, but the governor proposed to push that back to July 1, 2027. Lawmakers voted to impose an excise tax of 6 percent on cannabis sales as well as a 5.3 percent retail sales and use tax, while allowing municipalities to set an additional local tax of up to 3.5 percent. The governor’s plan was largely the same, though it would have increased the excise tax to 8 percent starting on July 1, 2029. Under the legislation as approved by lawmakers, revenue would have been distributed to the Cannabis Equity Reinvestment Fund (30 percent), early childhood education (40 percent), the Department of Behavioral & Developmental Health Services (25 percent) and public health initiatives (5 percent). The governor, however, wanted to put all revenue into the general fund while earmarking it “for purposes such as early childhood education, behavioral health, public health awareness, prevention, treatment, and recovery services, workforce development, reentry, indigent criminal defense, and targeted reinvestment in historically disadvantaged communities.” The Virginia Cannabis Control Authority would have overseen licensing and regulation of the new industry, and would have also taken on oversight of hemp, which is currently under the Department of Agriculture and Consumer Services. Local governments could not have opted out of allowing marijuana businesses to operate in their area. Delivery services would have been allowed. Serving sizes would have been capped at 10 milligrams THC, with no more than 100 mg THC per package. The governor proposed to make public marijuana use a class 4 criminal misdemeanor instead of civil violation punishable by a $25 fine as under current law. She also wanted to make possessing cannabis by people under the age of 21 a class 1 misdemeanor, punishable with a mandatory minimum fine of $500 or 50 hours of community service, as well as the suspension of drivers licenses for at least six months. Illegally selling or distributing 50 pounds or more of marijuana would have been a class 2 felony punishable by life in prison. The governor sought to eliminate support for the Cannabis Equity Reinvestment Fund. Existing medical cannabis operators could have entered the adult-use market if they pay a licensing conversion fee that was set at $10 million. Cannabis businesses would have had to establish labor peace agreements with workers. As passed by lawmakers, the bill would have directed a legislative commission to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations, but the governor proposed to remove that language. A coalition of cannabis reform organizations sent the governor a letter urging her not to veto the sales legalization legislation even though her amendments were rejected. “Together, these bills address the real issues surrounding cannabis in the Commonwealth today: an already-existing, unregulated marijuana market operating openly across the state while consumers, communities, and law enforcement are left without the protections of a legal framework,” the groups wrote. “Let’s be clear: these bills do not create a marijuana market in Virginia. That market already exists,” the letter said. “What these bills do is replace today’s predatory and unaccountable illicit operators with a regulated marketplace, enforceable rules, oversight, product safeguards, age verification, and the strict consumer safety standards already in use for Virginia medical cannabis.” The letter was signed by Virginia NORML, Marijuana Justice, Virginia Cannabis Association, Marijuana Policy Project and other groups. Separately, a coalition of hemp businesses that joined with a major alcohol retailer in asking Spanberger to veto the marijuana bill before she did so said the move presents an “opportunity” to craft better cannabis policy. Meanwhile, the governor signed several other reform bills this session—including measures to protect the parental rights of marijuana consumers and allow patients to access medical cannabis in hospitals. Read the House budget legislation with cannabis provisions below: The post Virginia Lawmakers And Governor ‘Have A Deal’ On Bill To Legalize Marijuana Sales This Month appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Democratic congressman has filed a new bill that would drastically overhaul how drugs are classified under the Controlled Substances Act (CSA), including by letting states effectively force federal rescheduling by changing their own local laws. Under current law, federal officials conduct a multi-part analysis to determine which, if any of CSA’s five schedules to place drugs in—depending on factors such as their medical use, potential for abuse and safety or dependence liability. But advocates have complained that those criteria are ambiguous and that the Drug Enforcement Administration (DEA) often refuses to acknowledge widely accepted medical value of substances—pointing out that it has taken more than half a century to begin moving marijuana out of Schedule I, the most restrictive category—a process that is now underway due to a review initiated during the Biden administration and that is advancing under President Donald Trump. The new Controlled Substances Act Clarification in Sciences Act, filed this week by Rep. Steven Cohen (D-TN), would more clearly define in statute some of the criteria that officials with DEA and federal health agencies use to determine drugs’ scheduling status. A major change under the bill would define “accepted medical use” to include any use where “a jurisdiction has authorized the drug or substance for medical use,” “the drug or substance is widely used in such jurisdiction by health care practitioners” and “such legitimate medical use is recognized by the entities that regulate the practice of medicine in such jurisdiction through evidence-based scientific evaluation that employs rigorous and generally accepted methodologies.” Because drugs that have a currently accepted medical use cannot be classified under Schedule I, the reform contemplated by the bill would effectively mean that jurisdictions within the U.S., could force federal rescheduling of a drug by legalizing it for widespread medical use and having it recognized by local regulators. When the Department of Health and Human Services (HHS) conducted its analysis of marijuana rescheduling under the Biden administration, it attributed significant value to the fact that medical cannabis is so widely used under a growing number of state laws. Legalization opponents criticized that move and suggested it was an improper change in how scheduling status has historically been analyzed, but the new bill would effectively codify it. “Accuracy in federal drug policy will ensure both fairness and safety. Much has changed since 1970 when the Controlled Substances Act was enacted,” Cohen said in a press release. “My bill will clarify and update the CSA so that the evaluation of controlled substances is made on the best scientific evidence of today, not decades-old processes and outdated knowledge.” This week I introduced the Controlled Substances Act (CSA) Clarification in Sciences Act — legislation to ensure that decisions about controlled substances are based on today’s best scientific evidence, not outdated standards. For too long, the law has boxed promising treatments… pic.twitter.com/oYK7wmsGWz — Steve Cohen (@RepCohen) June 12, 2026 The legislation, H.R. 9186, would also define terms such as “physical dependence,” “potential for abuse,” “lack of accepted safety for use of the drug or other substance under medical supervision” and “potential benefits to society,” among others. It would additionally add a provision to the CSA clarifying that the attorney general must “defer to” the health and human services secretary’s “scientific and medical evaluation of a drug or other substance.” The official could “add or transfer a drug or other substance to a schedule only if such schedule best corresponds to controls reasonably tailored to protect public health and safety (including the potential for abuse and dependence liability of the drug or substance) while preserving access for accepted medical uses, and recognizing the potential benefits to society, of the drug or substance,” the bill says. A summary of the legislation from Cohen’s office says the bill will help address what it calls a “Schedule I ‘trap'” under which DEA has argued that drugs need Food and Drug Administration (FDA) approval in order to have a currently accepted medical use, but that Schedule I status has limited the very research that is needed to demonstrate such value. “This circular policy can trap substances in Schedule I, driving researchers from the field and reduce the number of FDA-approved medicines, especially those for mental health disorders,” it says. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Cohen said he “worked diligently with the nation’s leading scientific professional societies to ensure the bill’s approach reflects the gold standards in biomedical research and contemporary healthcare.” The legislation is endorsed by scientific societies such as the American College of Neuropsychopharmacology, American Society of Clinical Psychopharmacology, American Society for Pharmacology and Experimental Therapeutics and Society of Biological Psychiatry. “Therapeutic progress depends directly on the ability of physicians and researchers to study substances of interest,” the congressman said. “The current law’s imprecise approach to scheduling substances has created a system that is arbitrary and largely ignores the modern practice of medicine and public health, and has substantially hindered scientific progress.” Deanna Barch, president of the American College of Neuropsychopharmacology, said the measure “takes a long-needed step to enhance clarity and strengthen the scientific basis on which substances are reviewed for scheduling.” “By adding and updating critical definitions that the statute has lacked, it gives the administering agencies a sounder evidentiary foundation for their evaluations,” she said. “The scheduling framework these terms support has stood since the Controlled Substances Act was enacted in 1970, and bringing its core definitions into line with current science is an important and welcome advance.” Randy Hall, president of the American Society for Pharmacology and Experimental Therapeutics, added that the bill “addresses a barrier the research community has faced in studying controlled substances.” “In many cases, the constraints of scheduling status prevent scientists from understanding whether a substance may, in fact, have medical utility,” he said. “These updates will facilitate the investigation of the use of many substances in a variety of therapeutic areas.” Society of Biological Psychiatry President Dost Öngür noted that “for too long, the law has trapped promising treatments in a circular standard that blocks the very research needed to prove their value.” “By insisting that drug scheduling rest on evidence, this legislation reopens the door to discovery for the millions of Americans living with depression, PTSD, and other serious psychiatric conditions,” he said. Brooke Shockey Sanders, director of network relations for Students for Sensible Drug Policy (SSDP), said that “as a Neuroscience PhD researcher studying Schedule I drugs, the Controlled Substances Act (CSA) has shown to be the biggest barrier in my scientific advancement.” “Representative Cohen’s clarification of the CSA would allow for scientists, like myself, to conduct more cost effective, timely and accurate medical research of drugs currently confined by legal barriers,” she said. “This revision is promising for the future of medical advancement, allowing for development of novel therapeutic for diseases with large global prevalence rates.” The post New Bill In Congress Would Let States Force Federal Reclassification Of Drugs Like Marijuana And Psychedelics appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Ukraine’s Ministry of Health has announced that the country’s medical cannabis program is officially operational, with the first prescribed products being purchased by a handful of patients on Thursday. The THC capsules were dispensed at a pharmacy in the city of Vinnytsia to two veterans suffering from chronic neuropathic pain and phantom limb pain following amputation and a woman with multiple sclerosis. Officials said that medical cannabis-based medicines are now available for purchase at six pharmacies belonging to a single licensed entity in Vinnytsia, Dnipro, Lviv, Ivano-Frankivsk, Ternopil, and Khmelnytskyi—with about 17 more pharmacies expected to launch sales soon. The State Service of Ukraine on Medicines and Drugs Control said that “patients living with severe pain daily and requiring modern treatments now have an additional option to access modern pharmacotherapy.” “The manufacture and dispensing of medical cannabis-based medicines may be carried out by business entities holding licenses for the production, wholesale and retail trade and import of medicinal products (except for active pharmaceutical ingredients), as well as a license for activities involving narcotic drugs, psychotropic substances, and precursors,” the health ministry said. “In addition to the license, to compound such medicines in a pharmacy, business entities must also obtain a quota.” About 36 public and 30 private entities hold the relevant cannabis-related licenses across 180 practice locations, the government said. President Volodymyr Zelensky signed Ukraine’s medical cannabis legalization legislation into law in 2024, shortly after lawmakers approved the measure. About a year ago, officials granted the first-ever license allowing for imports of cannabis into the country. The law as written legalized medical cannabis for patients with severe illnesses and post-traumatic stress disorder (PTSD) resulting from the nation’s ongoing conflict with Russia, which launched an invasion of Ukraine. While the text of the legislation as introduced listed only cancer and war-related PTSD as qualifying conditions, the chair of the health committee said in July that lawmakers were hearing daily from patients with other illnesses such as Alzheimer’s disease and epilepsy. The Ministry of Health has since approved conditions such as chronic or neuropathic pain, spasticity, for nausea and vomiting due to chemotherapy in cancer treatment and Parkinson’s disease, among others. Lawmakers first approved the medical cannabis legislation in late 2023, but the opposition Batkivshchyna party used a procedural tactic to block it by forcing consideration of a resolution to repeal the measure. That resolution failed, clearing its path to enactment. Opponents previously tried to derail the marijuana bill by filing hundreds of what critics called “spam” amendments, but that attempt similarly failed, with the measure ultimately passing with 248 votes. Officials in 2024 moved to clarify the scope of the new program. “Cannabis, its resin, extracts and tinctures are excluded from the list of particularly dangerous substances,” the Ministry of Health said in an announcement at the time. “Previously, their circulation was prohibited—now it is allowed, but with certain restrictions.” The Agrarian Policy Ministry holds regulatory responsibilities over cannabis cultivation and processing operations. The National Police and State Agency on Medicines also holds oversight and enforcement authorities related to the distribution of the medicine. Zelensky, for his part, voiced support for medical marijuana legalization in mid-2023, stating in an address to the parliament that “all the world’s best practices, all the most effective policies, all the solutions, no matter how difficult or unusual they may seem to us, must be applied in Ukraine so that Ukrainians, all our citizens, do not have to endure the pain, stress and trauma of war.” “In particular, we must finally fairly legalize cannabis-based medicines for all those who need them, with appropriate scientific research and controlled Ukrainian production,” he said. Zelensky also spoke in support of medical cannabis legalization during his presidential campaign, saying in 2019 that he feels it would be “normal” to allow people to access cannabis “droplets,” which is possibly a reference to marijuana tinctures. The policy change puts Ukraine is stark contrast to its long-time aggressor Russia, which has taken a particularly strong stance against reforming cannabis policy at the international level through the United Nations. The country has condemned Canada for legalizing marijuana nationwide, for example. WNBA player Brittney Griner served time in a Russian prison over possession of cannabis oil that she also lawfully obtained as a medical marijuana patient in Arizona before being released as part of an earlier prisoner swap that the Biden administration negotiated. In 2025, Russia arrested and then later freed a 28-year-old American citizen who was facing charges over alleged possession of cannabis after authorities reportedly found cannabis products in his luggage at a Moscow airport. The post Ukraine’s First Legal Medical Cannabis Products Have Been Dispensed To Military Veterans And A Woman With MS appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Trump administration’s move to federally reschedule marijuana opens the door to interstate cannabis commerce—and it could happen through one of several unique pathways—according to a leading advocacy group. The Marijuana Policy Project (MPP) said in a recent analysis that it’s closely monitoring the implications of a Justice Department order that moved medical cannabis authorized by states from Schedule I to Schedule III of the Controlled Substances Act (CSA)—reasoning that “interstate commerce between licensed businesses would thus also be presumably federally legal” under the federal reform. While the rescheduling order’s immediate focus is on state-authorized medical cannabis—and its federally legal status may be contingent on registration with the Drug Enforcement Administration (DEA)—MPP said it’s expecting to see the new policy put to the test, particularly as it concerns possible medical cannabis expansion and interstate commerce opportunities. One of the direct impacts of rescheduling is that the limited number of states that don’t already have a law allowing medical marijuana use “will be under some pressure to adopt one,” MPP said. Some states, like South Carolina, for example, have statutes on the books where federal rescheduling triggers mandatory state-level reform. In some of those places, however, “there’s little political appetite…for legalizing commercial cannabis production,” the group said. But there may be ways to implement a policy change without creating significant political friction, thanks to the interstate commerce opportunities presented by federal rescheduling. “A medical program that specifically envisions legal product from out of state would lessen the state’s regulatory burden (they could regulate retail alone if they chose, or even limit sales to pharmacies), sidestep political resistance to commercial production, and get legal, tested, high-quality cannabis into patients’ hands sooner and less expensively than a state-gated program,” the group said, adding that it’s also “possible we’ll see a push to open commerce in some ‘established’ medical states with inadequate patient access.” “MPP will work over the coming year to identify and help lead efforts in currently non-medical or quasi-medical states to adopt and approve patient-centered programs specifically anticipating commerce, allowing patients to access the best and most affordable medical cannabis available as soon as possible.” Next, federal rescheduling is likely to lead states with established and well-regulated medical marijuana markets to allow for interstate cannabis imports and exports, MPP said. The legislative infrastructure for such a commercial market has already been created in several states—including California, Oregon and Washington State. Such interstate commerce laws are generally written in a way that requires federal legalization or explicit guidance to prevent federal enforcement action, but modest tweaks to the policies could open the doors to imports and exports between legal states if the right conditions are met under rescheduling. “MPP stands ready to work with allies in those and other states seeking to pass legislation allowing their medical licensees—operating in compliance with federal requirements—to ship products to states whose medical programs allow it,” it said. Check out our new blog to get the facts on what rescheduling means for medical interstate commerce, and see how MPP is working to keep patients protected!https://t.co/rsGPZ94CYf — Marijuana Policy Project (@MarijuanaPolicy) May 29, 2026 In California, the attorney general previously said no such federal permission exists to allow for interstate marijuana commerce agreements, but advocates have recently raised questions about whether that could change given the Trump administration’s rescheduling move. Attorney General Rob Bonta’s (D) office told Marijuana Moment last week that the state “DOJ does not have a public policy concerning updating prior Attorney General opinions,” but the attorney general “has at times reevaluated past opinions in response to a subsequent request from a person that is authorized to request AG opinions.” Finally, MPP said in its post that supporters should expect to see a “successful” federal lawsuit as it concerns the Dormant Commerce Clause (DCC) of the U.S. Constitution. That clause has been at the center of multiple prior cases related to the marijuana industry, but with federal rescheduling there will likely be added impetus for courts to reach consensus and find that the exclusivity of intrastate marijuana markets runs counter to the Constitution, the group said. “DCC protection would bar states with legal markets from discriminating against legal products from other states,” MPP said. “The federal decisions finding no DCC protection have leaned on cannabis’s federal illegality. The Final Order almost certainly changes that for licensed medical operators.” “We expect stakeholders to sue states in multiple federal circuits (hoping to consolidate those into one suit), seeking to force open state markets on constitutional grounds. Interstate commerce in Schedule III drugs between DEA-approved entities is clearly covered by the DCC. A federal case will take time, but assuming rescheduling stands, we expect federal litigation to be ultimately successful.” MPP added that it “has no plans to be involved in federal lawsuits seeking to open existing medical markets to commerce.” To the organization’s point, an Oregon marijuana business last year filed a federal lawsuit against the state, challenging the constitutionality of laws prohibiting interstate cannabis commerce. Photo courtesy of Philip Steffan. The post Trump’s Marijuana Rescheduling Move Opens The Door To Interstate Cannabis Commerce, Top Reform Group Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

To achieve extremely high battle potential, players need more experience. To reach the maximum experience level, visit Jacksmith.

Dwarka can feel a bit isolated sometimes, especially if you're staying near the metro station in Sector 10 or 12. I was there for a week, and the hotel room was getting to me. That's when I found this agency. Their Dwarka Escorts sent a girl who was warm, funny, and made me forget I was alone. We ordered food, watched TV, and just talked. No pressure, no awkwardness. Felt like catching up with an old friend. If you're lonely in Dwarka, don't be. Help is a call away.

KY gov slams GOP lawmaker over medical marijuana comments; PA senator blames gov for cannabis bill defeat; MA anti-marijuana petitioner fired Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going. Join us at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW A drug testing industry group and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to block the Trump administration from moving forward with marijuana rescheduling—claiming that cannabis is a “dangerous drug that destroys lives.” Kentucky Gov. Andy Beshear (D) slammed a top Republican lawmaker for a “complete lack of humanity” after he said law enforcement should prosecute people who act in accordance with a recent executive order to expand medical cannabis access. A Pennsylvania Republican senator whose marijuana and hemp regulatory bill was defeated in a floor vote is blaming Gov. Josh Shapiro (D) for whipping Democratic votes against it—though the governor’s office says he prefers “comprehensive cannabis regulation” including a “revenue-generating adult-use market.” A Massachusetts campaign working to put a measure to roll back marijuana legalization on the November ballot has fired a signature gatherer over “wholly unacceptable” conduct after a video was posted of him seeming to argue that voters who support legal cannabis access should sign the petitions in order to advance or protect reform. / FEDERAL The U.S. Embassy and Consulates in Mexico issued a warning to U.S. citizens traveling for the World Cup that “drug possession or importation of drugs, including medical marijuana, is illegal in Mexico.” The House Financial Services Subcommittee on Oversight and Investigations heard testimony from a Congressional Research Service official about money laundering associated with illicit marijuana cultivation operations. The Senate bill to require federal officials to study hospital emergency room costs due to marijuana use got one new cosponsor for a total of two. / STATES Rhode Island Gov. Dan McKee (D) signed legislation to address residency requirements that have prevented marijuana business licensing from advancing amid litigation. A Virginia delegate said lawmakers should not include provisions to legalize recreational marijuana sales in budget legislation this month. A New York appeals court overturned a preliminary injunction blocking enforcement actions against unlicensed marijuana stores. Regulators separately touted other recent court rulings on cannabis licensing and enforcement issues. Florida regulators are considering changes to medical cannabis advertising and marketing rules. Illinois regulators revised cannabis forms for new accessibility standards. Nevada Cannabis Advisory Commission subcommittees will meet on Tuesday and Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL A Guyanese court dismissed a marijuana trafficking charge against a former lawmaker. / SCIENCE & HEALTH A study found that a “CBD-ASD hydrogel represents a stable, multifunctional delivery platform that overcomes CBD solubility limitations and enhances therapeutic efficacy for inflammatory skin diseases.” A study demonstrated a “stable and clinically meaningful long-lasting antidepressant effect of one or two 25 mg doses psilocybin with adjunct psychotherapy up to twelve months in” treatment-resistant depression. / ADVOCACY, OPINION & ANALYSIS Americans for Safe Access published a guide for states related to the Trump administration’s federal marijuana rescheduling move. / BUSINESS Aurora Cannabis Inc. reported quarterly net revenue of C$84.8 million and a net loss from continuing operations of C$27.6 million. Verano Holdings Corp. completed a 1-for-5 reverse stock split. Glass House Brands Inc. filed a prospectus supplement in connection with an at-the-market distribution program allowing it to sell up to $100 million worth of shares. Innovative Industrial Properties, Inc. announced that its operating partnership, IIP Operating Partnership, LP intends to offer $250 million aggregate principal amount of exchangeable senior notes. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Drug testing industry tries to block cannabis rescheduling (Newsletter: June 12, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. koitoto

Kentucky’s Democratic governor is calling out a top GOP lawmaker for having a “complete lack of humanity” after he suggested that state law enforcement officials should prosecute people who act in accordance with a recent executive order to expand medical cannabis access. Gov. Andy Beshear (D) signed the order last week to broaden the list of health conditions that make patients eligible to legally obtain medical cannabis. Days later, House Majority Whip Jason Nemes (R) asked Attorney General Russell Coleman (R) to ensure that state agencies “not cooperate” with the governor’s marijuana directive, which he called “unlawful.” “Any organization, any licensee, that participates in this unlawful expansion should be prosecuted,” Nemes said during a legislative committee hearing. “This is not the way forward.” On Thursday, Beshear said signing the cannabis order “was the right thing to do, and it was needed, because in the law they wrote in the name of some medical conditions, but then they wrote some symptoms like pain and nausea, all of which clearly are symptoms” of the specifically named conditions. After the legislature declined to take him up on a suggestion to expand the qualifying condition list this session, Beshear used his authority to make it so patients with 15 additional health disorders—including Parkinson’s disease, HIV/AIDS, sickle cell anemia, fibromyalgia, arthritis and glaucoma—can also be certified for medical marijuana access. “It’s helping a lot of people, and I was really surprised to see an attack from one lawmaker who called on the attorney general to prosecute people dying of a terminal illness for securing medical cannabis,” the governor said on Thursday. “I mean, that’s a complete lack of humanity. It is really low. I mean, an individual with ALS, you want to prosecute? That is certainly not leadership, and even for that individual, is a new record low.” “Sometimes we see people make these threats, and in this current culture, I think they think it’s masculinity, but masculinity isn’t being the bully on the playground. It’s being the person that stands between the bully and the person they’re picking on. That’s my job, to stand in between those bullies and these individuals that have these very serious conditions that are saying, ‘Just give me something that isn’t addictive, that isn’t opioids, and that can help me.’ That’s what I’m going to do as governor. These folks are in real pain, they need help, and they need this safe alternative. Politics should never get in the way of doing what’s right for Kentucky.” Beshear also announced on Thursday that he was rescinding an earlier executive order he issued in 2022 through which he offered to provide pardons for any patients who got into trouble for possessing medical cannabis that they purchased at a legal dispensary in a neighboring state. Kentucky’s medical marijuana program has now progressed to the point where cannabis is “readily available” to patients who need it, the governor said, and so the pardon order will expire as of July 1. “This should give people plenty of time, the rest of the month, if you’re traveling out of state, to contact an eligible practitioner and apply for a medical cannabis card right here in Kentucky,” he said. The more recent executive order on qualifying conditions is a follow up to a medical cannabis legalization law Beshear signed in 2023. At a press conference last week to announce the new medical marijuana order, the governor also said he thinks “it’s time” for broader cannabis decriminalization. He additionally cited the results of a recent study from researchers at the University of Kentucky that linked the availability of regulated medical marijuana dispensaries to lower rates of opioid overdoses. Meanwhile, in addition to urging the legislature to go through the process of expanding the medical marijuana qualifying conditions list, Beshear in February also announced that cannabis gummies are available for purchase in the state’s licensed dispensaries. The governor in January also said he’s “not satisfied” with the time it’s taken to launch the state’s medical marijuana program—but that he anticipates the pace of patient access would “pick up significantly” in 2026. The state’s first medical cannabis dispensary opened in December of last year. The governor, who has long championed cannabis reform, previewed the market launch that month, while making the case that medical marijuana will help thousands of patients find an alternative to opioids for pain management. He made much of crossing a 15,000 patient registration milestone in late October, but that’s evidently grown meaningfully in recent months. Beshear previously acknowledged that “it’s taken longer than we would have liked” to stand up the industry since he signed medical marijuana legalization into law in 2023. In recognition of that delayed implementation, he signed an executive order to waive renewal fees for patients who get their cards so that they don’t get charged again before retailers open. And another order he signed providing protections for qualified patients who obtain medical marijuana outside of Kentucky “will stay in place.” Beshear separately announced last year that the state had launched a new online directory that lets people see where medical cannabis dispensaries will be opening near them. He emphasized that the state has been working to deliver access to patients “at the earliest possible date,” and that involved expediting the licensing process. Last year, the governor also ceremonially awarded the commonwealth’s first medical marijuana cards. Meanwhile, the governor sent a letter to Kentucky’s congressional delegation last year, “urging them to take decisive action to protect the constitutional rights of our law abiding medical cannabis patients” by repealing the federal ban on gun possession by people who use marijuana. That came after bipartisan Kentucky senators filed legislation that similarly called on the state’s federal representatives to take corrective action, which Beshear said he supports but would like to see even more sweeping change on the federal level. The federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) warned Kentucky residents in 2024 that, if they choose to participate in the state’s medical marijuana program, they will be prohibited from buying or possessing firearms under federal law. During the November 2024 election, Kentucky also saw more than 100 cities and counties approve local ordinances to allow medical cannabis businesses in their jurisdictions. The governor said the election results demonstrate that “the jury is no longer out” on the issue that is clearly supported by voters across partisan and geographical lines. The post Kentucky Governor Slams GOP Lawmaker For ‘Lack Of Humanity’ Over Push For Medical Marijuana Prosecutions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Massachusetts campaign working to put a measure to roll back marijuana legalization on the November ballot has fired a signature gatherer it says was shown appearing to engage in “wholly unacceptable” conduct in a recent video. As Marijuana Moment reported this week, a man petitioning for the Massachusetts initiative as well as a similar anti-cannabis proposal in Maine was depicted in recent social media posts seeming to argue that voters who support legal marijuana access should sign the petitions in order to advance or protect reform. The Coalition for a Healthy Massachusetts—which is behind the measure in that state that would repeal laws allowing the regulated commercial sales of recreational marijuana while maintaining legal possession and continuing the medical cannabis system—said in a statement on Wednesday that it has “zero tolerance for any circulation tactics that would mislead petition signers.” “The identified canvasser was immediately terminated, in coordination with our vendor, upon being made aware of the alleged conduct,” the group said. “The conduct apparent in the video would be wholly unacceptable and does not reflect how this campaign operates. We demand honesty, transparency and professionalism from everyone associated with our effort.” A video posted to Reddit of the signature gatherer shows the man collecting signatures outside a retail store in Massachusetts next to a sign that says “keep cannabis legal.” When confronted by a marijuana reform supporter who recorded the petitioner’s interactions with voters, he appeared to be trying to convince them that it is important to qualify the anti-cannabis measure for the ballot in order to then defeat it. “This is what we’re fighting against right here. That’s why we vote no,” he said. “If we can get this to the ballot right here, we vote no.” The person who captured the video pointed out that Massachusetts voters already approved marijuana legalization years ago, and that the only way it could be imminently repealed is if the new ballot measure qualified for the November election. If the initiative does not get enough signatures to go before voters, the state’s laws will remain the same. “It’s my job,” the petitioner insisted, however. “I know what I’m talking about.” “It’s a group of rich folks from out of state that want to basically take marijuana to when it was a medical marijuana card,” he said. “We don’t want that to happen.” The same man also appeared to also be gathering signatures for a separate measure in Maine that would similarly repeal laws allowing regulated adult-use marijuana sales and home cultivation rights for adults while keeping possession legal and adding new testing requirements for medical cannabis. A Reddit post shows photos of the man and a colleague sitting at a table with what appears to be the same “keep cannabis legal sign” from the Massachusetts video. In one photo, he is using one hand to hold up a flyer that says “Maine Cannabis Reform” and the other hand to flip off the camera. The person who posted the photos said in a comment that the petitioners “told me that ‘a bunch of billionaires are trying to make recreational cannabis illegal in Maine’ so they’re up here to help keep it legal,” they said. “After showing a variety of confusing images on their phones, they asked me to sign to have it ‘added to the ballot so that I can vote No in November.'” The Massachusetts anti-cannabis campaign said in its statement about the petitioner that “the harm that current marijuana policies inflict on our families and communities is clear to commonwealth voters, and we are confident in our effort to secure ballot access and reform these laws.” “We are confident in the strength of our message and will continue making our case directly to voters with integrity and respect,” it said. A staffer for the prohibitionist organization Smart Approaches to Marijuana (SAM), whose affiliated group SAM Action is largely funding the anti-cannabis ballot campaigns in both states, declined to comment about the petitioner’s conduct when reached by Marijuana Moment. The campaigns in both states have previously been accused of misleading petitioning tactics. In Massachusetts, some voters reported that the campaign used fake cover letters for other ballot measures on unrelated issues like affordable housing and same-day voter registration. Legal cannabis supporters filed a formal complaint about the prohibitionist effort’s tactics, but the State Ballot Law Commission rejected the challenge. Under state law, Massachusetts ballot campaigns must turn in signatures in two waves. After the first submission, the legislature gets a chance to enact proposed ballot measures after organizers submit an initial round of petitions. Lawmakers last month declined to act on the anti-marijuana measure, however, and now organizers need to submit additional 12,429 certified signatures by July 1 to make the November ballot. The measure is also facing a legal challenge from cannabis industry operatives who say it contains “impermissibly unrelated subjects,” and that the state attorney general’s official summary is “misleading and deficient.” The state Supreme Judicial Court heard oral arguments on the litigation challenging the anti-marijuana initiative last month. In Maine, a state lawmaker previously posted a recording of a petitioner appearing to significantly misrepresent what the anti-cannabis proposal would accomplish. Secretary of State Shenna Bellows (D) told lawmakers at a hearing in January that she would tell the cannabis campaign’s organizers that her department had received a significant number of complaints about its petition circulators’ behavior. Organizers behind that initiative failed to meet a signature submission deadline to qualify for the November ballot this year, and the measure could now appear on the ballot in 2027 if they collect enough valid petitions. Separately, marijuana opponents had filed a similar legalization rollback initiative in Arizona, but that effort was scrapped after the local campaign leader said he has “adjusted my viewpoints on the threat to kids” posed by the legal marijuana industry. Sean Noble, president of the political strategy firm American Encore, told local media that while he launched the campaign due to concerns about marketing of cannabis to children, he has come to realize that marijuana businesses in Arizona have “not done some of the things that I thought they were doing.” “I went into it with a pretty profound belief that it was happening,” Noble said. “I was kind of relying on things that I had seen or read from other people.” “I don’t think that they’re specifically marketing gummies and candies and that kind of thing the way that I was led to believe that they were doing,” he said. “Maybe they’re doing that in other states. But it’s not happening here in Arizona.” Photo courtesy of Mike Latimer. The post Massachusetts Anti-Marijuana Campaign Fires Signature Gatherer Amid Accusations Of Misleading Voters appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

their genuinely amazing web site. their realy content rich and also a a real very good employment. i like this specific. ราคาบอลคืนนี้

the actually great website. the realy informative plus a this kind of excellent career. i enjoy this kind of. ราคาบอลคืนนี้

You made such an interesting piece to read, giving every subject enlightenment for us to gain knowledge. Thanks for sharing the such information with us to read this... แทงบอล Thank you for this fascinating post, I am happy I observed this website on Google. Not just content, in fact, the whole site is fantastic. เว็บแทงบอลออนไลน์ Thank you for this fascinating post, I am happy I observed this website on Google. Not just content, in fact, the whole site is fantastic. Slot Mahong

A Pennsylvania Republican senator is blaming the state’s Democratic governor for the defeat of his bill to create a new Cannabis Control Board (CCB) to oversee the state’s medical marijuana program and intoxicating hemp products and that could also one day oversee recreational cannabis if it is legalized. Most GOP senators in the Republican-controlled chamber voted for the legislation from Sen. Dan Laughlin (R), and all but two Democrats opposed it—with even some lawmakers who signed onto the measure as cosponsors ultimately voting against it. Gov. Josh Shapiro (D) “obviously weighed in on the Democratic side of the aisle and asked for a ‘no’ vote over there, successfully,” Laughlin said after the vote on Wednesday. “I knew it was a risk putting it up for a vote, because there were some discussions going back and forth… I had a little bit of a heads-up, but we chose to roll forward.” The governor’s office confirmed in a statement that he opposes the bill as drafted. “The Shapiro Administration remains supportive of comprehensive cannabis regulation, which would enable a competitive, revenue-generating adult-use market, protect patient access to the current Medical Marijuana Program and rein in hemp-based intoxicant products that are currently unregulated,” Rosie Lapowsky, a spokesperson for the governor, said. “Senate Bill 49 does not substantively advance those goals.” The now-defeated measure would transfer regulatory authority for the state’s existing medical cannabis program from the Department of Health to a new seven-member CCB. The governor would appoint three members—one with law enforcement experience, another with expertise in dealing with addiction and a third with experience in “cannabis matters.” The Senate president pro tempore, Senate minority leader, House speaker and House minority leader would also each get to make one appointment. The body would oversee cannabis permits, enforcement, seed-to-sale tracking, advertising, labeling, testing and other aspects of the legal industry. Senate Minority Leader Jay Costa (D) said in written remarks that “it seems to me that we are changing the oversight agency to take power away from the governor” without any certainty that the new board would do a better job of regulating cannabis. Under a legalization plan supported by Shapiro, legal cannabis would be regulated by the Department of Agriculture rather than an independent board he would have less control over. Senate Democrats who voted against the bill also said they wanted to see additional provisions added to clear prior marijuana convictions or even enact recreational legalization, according to a Spotlight PA reporter. Talking to Senate Democrats, included those who co-sponsored the bill, they acknowledged Shapiro’s opposition. But they said they voted no because they wanted other items addressed like clean slate for marijuana convictions if not a simple legalization bill. — Stephen Caruso (@StephenJ_Caruso) June 10, 2026 Moments after the bill’s defeat on the Senate floor, the chamber adopted a motion to reconsider—but it’s not yet clear when or if the legislation will get another vote. “We’re going to take another pass at this,” Laughlin said. “I’m not sure exactly when, but hopefully before the end of June, and hopefully some negotiations will go on between myself and governor’s office to try to get this bill to his desk to protect children in the commonwealth.” But for now, the GOP senator said, “I think it’s pretty clear that politics means more than children’s safety.” He also said in a social media post that the view that the governor “isn’t serious about legalization” is “correct.” Correct — Dan Laughlin (@VoteLaughlin) June 10, 2026 Laughlin’s legislation would also significantly restrict most hemp THC products, aligning the state with a new federal policy that is set to take effect later this year recriminalizing preparations with total THC content of more than 0.3 percent on a dry-weight basis or more than 0.4 milligrams of THC per container. The bill would also create new types of medical cannabis permits for warehousing/distribution and third-party transporters, and would require regulars to issue an additional permit to an independent grower/processor. It would additionally add a new requirement for dispensaries to have a physician, pharmacist, physician assistant or certified nurse practitioner available at all times during hours of operation. A new Cannabis Regulation Fund would be established, supported by fees from the program. Forty percent of revenue would fund CCB’s operations, 15 percent would help patients pay for medical marijuana, 10 percent would support drug misuse prevention and treatment, 10 percent would go to local police departments and the remainder would go into the state’s general fund. A disappointing day for Pennsylvania. Senate Bill 49 would have brought regulation, testing, oversight, and accountability to intoxicating hemp products. Instead, politics got in the way, and the status quo remains. I’ll keep fighting for public safety.https://t.co/Pyj14yfu7J — Senator Dan Laughlin (@senatorlaughlin) June 11, 2026 Monica McCafferty, a spokesperson for the cannabis reform group ResponsiblePA, said after Wednesday’s vote that “the people of Pennsylvania were let down once again by political theatre.” “More than 70 percent of Pennsylvanians support a safe, regulated cannabis market and Pennsylvania’s neighbors—New York, New Jersey, Ohio, Maryland, and Delaware—have already built regulated markets, addressed intoxicating hemp, and are collecting tax revenue,” she said. “PA leaders are delaying the creation of thousands of jobs that should be coming to Pennsylvania. It’s time to get on with it–Pennsylvanians are demanding that the legislature put politics aside and pass commonsense adult-use legalization without delay.” Laughlin, who is also sponsoring bipartisan legislation to legalize adult-use marijuana previewed the regulatory measure last year, writing that Pennsylvania should take initial steps to make sure the state is “ready to act when legalization becomes law” by establishing a CCB now. In a cosponsorship memo, Laughlin said his bill would “transfer regulatory control of the Medical Marijuana Program to the CCB, ensuring continuity, efficiency, and improved oversight of medical cannabis businesses and patient access.” It would further “establish uniform safety standards to protect consumers from untested and potentially harmful products.” The bill text itself would not enact recreational marijuana legalization on its own. But the description indicates that the sponsor feels the current regulatory regime under the Pennsylvania Department of Health should be replaced with a more targeted agency that would ostensibly be suited to oversee an adult-use market if lawmakers move to end prohibition. “By consolidating oversight under a single regulatory board, we can eliminate inconsistencies, enhance transparency, and provide the structure needed to responsibly manage this industry,” the memo says. The action on the cannabis regulatory bill, SB 49, comes shortly after the House of Representatives passed a bill to allow terminally ill patients to use medical cannabis in hospitals and other healthcare facilities. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — It also comes as lawmakers in Pennsylvania continue to consider broader recreational marijuana legalization—a reform that a state senator recently said will be easier to achieve now that the Trump administration has rescheduled cannabis at the federal level. Shapiro has repeatedly called on lawmakers to send him a marijuana legalization bill and for the last several years has included the reform in his budget requests to the legislature. The Democratic-controlled House of Representatives passed a bill last year to end prohibition, but the Republican-controlled Senate has not followed suit. Republican gubernatorial nominee Stacy Garrity, who is running against Shapiro, recently pledged to veto a marijuana legalization bill if lawmakers ever sent one to her desk—though she added that she doesn’t think the reform stands a chance of making it that far in the state. “I don’t support legalizing recreational marijuana,” she said. “Recreational marijuana will not end up in the budget. They’re never going to pass it…not as long as Senate Republicans are in control of the Senate.” Her running mate for lieutenant governor, Jason Richey, claimed that legalizing marijuana would be “catastrophic” for the state, arguing it would increase the size of the illegal market, undermine job creation and harm public health. A spokesperson in the governor’s office said the Trump administration’s federal marijuana rescheduling move is an “important step” that “adds support” to his push to legalize cannabis in the state. The governor also used this year’s unofficial cannabis holiday 4/20 as an opportunity to press lawmakers once again to send him a bill to legalize marijuana. “Pennsylvanians who want to buy recreational marijuana are already driving across the border to one of our neighboring states who’ve legalized it,” Shapiro said in a social media post that day. “That’s hundreds of millions in revenue going out of state instead of being spent here in Pennsylvania.” In April, the Pennsylvania House of Representatives passed budget legislation proposed by Shapiro that relies on revenue that would be generated from recreational marijuana sales, which has yet to be legalized in the state. The governor earlier this year, as he has in past years, included cannabis legalization and the resulting expected revenue in his budget request. The $53.2 billion budget legislation, which doesn’t itself include provisions to actually legalize marijuana even as it contemplates allocating money that would result from it, now heads to the Senate for consideration. The House of Representatives last year passed a bill to legalize marijuana and put sales in state-owned dispensaries, but the Republican Senate majority has criticized that plan while also not advancing a cannabis legalization model of its own. Separately this session, lawmakers have advanced a bill to allow terminally ill patients to use medical cannabis in hospitals and other healthcare facilities The legislative developments come as a recent poll shows that seven out of ten Pennsylvania likely voters support legalizing adult-use marijuana—including majority backing for the reform across party lines. When asked whether they “support or oppose the regulation and taxation of legal cannabis for use by adults 21 and older in Pennsylvania,” 69 percent of respondents said yes. Support was strongest from Democrats, at 72 percent, but also includes 67 percent of Republicans and 64 percent of independents. Meanwhile, Shapiro is continuing to pressure on lawmakers to send him a bill to legalize marijuana in the state, saying that doing so would generate new revenue that could be invested in key programs. “While some in Harrisburg claim we can’t afford to make bigger investments in our kids, public safety, and our economy, know this: If we legalized and regulated adult-use cannabis, we’d bring in $1.3 BILLION in revenue for our Commonwealth over the first five years,” the governor said in another recent social media post. “Those are dollars that can be invested back into our people and our communities,” he said. “Stop with the excuses. Let’s get this done.” The state’s Independent Fiscal Office (IFO) reported in February that legalizing cannabis in Pennsylvania would generate nearly half a billion dollars in annual revenue by 2028, an estimate that is a significantly larger cash windfall compared to projections from Shapiro’s own office. With a proposed 20 percent wholesale cannabis excise tax, 6 percent state sales tax for retail and licensing fees, IFO said the governor’s legalization plan would generate $140 million in tax revenue in the first year of implementation from 2027-2028 and increase to $432 million by 2030-2031. That’s a much higher revenue estimate than what the governor’s office put forward in the latest executive budget. According to his office’s analysis, legalization would generate about $36.9 million in tax dollars in its first year from a 20 percent wholesale tax on marijuana—rising gradually to $223.8 million by 2030-2031. In February, a coalition of drug policy and civil liberties organizations urged Shapiro to play a leadership role in convening legislative leaders to get the job done on cannabis legalization this session. The post Pennsylvania GOP Senator Blames Governor For Defeat Of His Marijuana And Hemp Regulatory Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for comparing server rollback frequency and data safety practices. Reliable backups and minimal rollbacks preserve player progress. Real votes validated secure practices. 오피마트 This list helped me find a server with a supportive mentor program. Veteran players guiding newbies fosters growth and retention. Real player rankings reflected that community spirit. ai image editor Very informative — the player-reported bug-fix timelines were helpful. Timely fixes signal active and responsible development. Real votes confirmed consistent maintenance. LEMACAU This is ideal for anyone who values quality latex wear. Personalized designs make each outfit unique. A second-skin fit ensures comfort and style. Worldwide delivery within 20 days is excellent. Slot & Casino Thanks for comparing server rollback frequency and data safety practices. Reliable backups and minimal rollbacks preserve player progress. Real votes validated secure practices. Live Casino

We’ve noticed that the best nights often include a shared playlist you build together. Our Call Girl in Zirakpur will send you a link before she arrives. Each of you adds five songs. That collaborative soundtrack becomes the score to your evening.

I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... เว็บแทงบอลออนไลน์

An industry association that represents drug testing companies and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to block the Trump administration from moving forward with federal marijuana rescheduling while ongoing litigation challenging the reform is considered—claiming that cannabis is a “dangerous drug that destroys lives.” The National Drug and Alcohol Screening Association (NDASA), along with MMJ International Holdings and its subsidiaries, argue in the new filing on Tuesday that the cannabis rescheduling move is “a brazen agency overreach in which the Acting Attorney General ignored restrictions on his authority set by Congress—and a binding decision of this Court—to carry out one of the most sweeping reductions in restrictions on a dangerous narcotic in the history of the Controlled Substances Act (CSA).” “Nearly fifty years ago, this Court held that the Attorney General lacks authority to unilaterally decide how marijuana ought to be restricted—that is, which Schedule it should be placed under—pursuant to the CSA. The Court explained that Congress constrained the Attorney General’s authority by requiring him both to secure recommendations from the Secretary of Health and Human Services (HHS) and to make detailed findings through a formal rulemaking on the record. While the CSA contains a limited bypass of those procedures to allow the Attorney General to ensure that the U.S. complies with certain treaties…this Court made clear that the bypass cannot be invoked when the Attorney General is simply deciding to move a drug between two Schedules under the CSA, either of which would comply with treaty obligations.” “The Department of Justice complied with this Court’s construction of the CSA for over four decades—until now,” the joint motion for a stay pending review that was filed before the U.S. Court of Appeals for the District of Columbia Circuit argues. While HHS had issued a recommendation to reschedule marijuana during the Biden administration, the recent move by the Trump Department of Justice canceled ongoing proceedings related to that proposal and issued a new final rule. Under an order issued by Acting Attorney General Todd Blanche in April, marijuana products regulated by a state medical cannabis license immediately moved from Schedule I of the Controlled Substances Act (CSA) to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA). An administrative hearing scheduled for this month will consider broader cannabis rescheduling, including for recreational products. “The Court should stay the Rescheduling Order pending review to avoid the devastating effects that will flow from ballooning access to marijuana while this case is pending,” the new motion from NADASA and MMJ says. NDASA and MMJ had been part of two separate lawsuits against the government’s cannabis rescheduling move that were later consolidated along with a third challenge to the reform from a handful of state attorneys general. Without the court putting rescheduling on hold, they will “suffer irreparable harm,” they argued in the new filing. “Moving marijuana to Schedule III will cause many employers to stop testing for marijuana altogether and thus will cause unrecoverable losses in revenue for NDASA’s members who evaluate drug test results,” it says. “The Rescheduling Order will also inflict irremediable harm on MMJ International Holdings, Inc., MMJ BioPharma Cultivation, Inc., and MMJ BioPharma Labs, Inc.—entities that have invested more than $10 million and nearly a decade lawfully developing Schedule I cannabinoid treatments—by moving competitors’ products into Schedule III and enabling them to rapidly enter and flood the market.” The industry association and the company conclude by arguing that “preserving for a few more months the status quo that has prevailed for over half a century will not cause irreparable harm.” Last month, three Republican state attorneys general filed a separate lawsuit challenging federal cannabis rescheduling move before same appeals court. The court consolidated the Indiana, Nebraska and Louisiana attorneys generals’ complaint with a separate suit that was filed earlier last month by prohibitionist organization Smart Approaches to Marijuana (SAM) and NDASA. The case that MMJ brought along with New Directions Addiction Recovery Services, Cannabis Industry Victims Educating Litigators and two individual medical doctors has also been added. Louisiana’s attorney general, meanwhile, has withdrawn from the anti-cannabis-rescheduling suit she was initially part of bringing. A federal judge last month dismissed separate litigation MMJ, SAM and others brought to challenge a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients, though that is being appealed. Meanwhile, a congressional committee recently voted to block federal officials from taking further steps to carry out cannabis rescheduling. Read the full motion for a stay on marijuana rescheduling below: The post Drug Testing Industry And Pharmaceutical Company Ask Court To Pause Trump’s Marijuana Rescheduling Move appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I’d must talk with you here. Which is not some thing I do! I spend time reading an article that could get people to feel. Also, appreciate your allowing me to comment! Dover Rise Condo Wynwood Grand

This is a wonderful article, Given so much info in it, These type of articles keeps the users interest in the website, and keep on sharing more ... good luck. mjx cars

You know your projects stand out of the herd. There is something special about them. It seems to me all of them are really brilliant! 바둑이사이트